These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12692838)

  • 1. Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas.
    Pinto M; Oliveira C; Cirnes L; Carlos Machado J; Ramires M; Nogueira A; Carneiro F; Seruca R
    J Pathol; 2003 May; 200(1):32-8. PubMed ID: 12692838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation.
    Kim WS; Park C; Hong SK; Park BK; Kim HS; Park K
    Anticancer Res; 2000; 20(3A):1499-502. PubMed ID: 10928062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
    Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
    J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Damage to the transforming growth factor TGF-beta type II receptor gene and microsatellite instability in carcinoma cells of the gastrointestinal tract].
    Vostriukhina OA; Nikiforova IF; Shtam TA; Kantorov SL; Kovalev VK; Vasil'ev SV; Pozharisskiī KM; Lantsov VA
    Vopr Onkol; 1998; 44(6):667-71. PubMed ID: 10087960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers.
    Takenoshita S; Tani M; Nagashima M; Hagiwara K; Bennett WP; Yokota J; Harris CC
    Oncogene; 1997 Mar; 14(10):1255-8. PubMed ID: 9121777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
    Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
    Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.
    Takenoshita S; Mogi A; Tani M; Osawa H; Sunaga H; Kakegawa H; Yanagita Y; Koida T; Kimura M; Fujita KI; Kato H; Kato R; Nagamachi Y
    Oncol Rep; 1998; 5(2):367-71. PubMed ID: 9468559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric carcinomas with microsatellite instability: clinical features and mutations to the TGF-beta type II receptor, IGFII receptor, and BAX genes.
    Iacopetta BJ; Soong R; House AK; Hamelin R
    J Pathol; 1999 Mar; 187(4):428-32. PubMed ID: 10398102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
    Tanaka S; Mori M; Mafune K; Ohno S; Sugimachi K
    Br J Cancer; 2000 May; 82(9):1557-60. PubMed ID: 10789724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta.
    Baker K; Raut P; Jass JR
    J Pathol; 2007 Nov; 213(3):257-65. PubMed ID: 17893910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of the transforming growth factor-beta type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterations.
    Iacopetta BJ; Welch J; Soong R; House AK; Zhou XP; Hamelin R
    J Pathol; 1998 Apr; 184(4):390-5. PubMed ID: 9664904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birt-Hogg-Dubé (BHD) gene mutations in human gastric cancer with high frequency microsatellite instability.
    Jiang W; Fujii H; Matsumoto T; Ohtsuji N; Tsurumaru M; Hino O
    Cancer Lett; 2007 Apr; 248(1):103-11. PubMed ID: 16870330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability.
    Kim H; Kim YH; Kim SE; Kim NG; Noh SH; Kim H
    J Pathol; 2003 May; 200(1):23-31. PubMed ID: 12692837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability-associated mutations associate preferentially with the intestinal type of primary gastric carcinomas in a high-risk population.
    Chung YJ; Song JM; Lee JY; Jung YT; Seo EJ; Choi SW; Rhyu MG
    Cancer Res; 1996 Oct; 56(20):4662-5. PubMed ID: 8840981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.
    Oliveira C; Velho S; Domingo E; Preto A; Hofstra RM; Hamelin R; Yamamoto H; Seruca R; Schwartz S
    Oncogene; 2005 Nov; 24(51):7630-4. PubMed ID: 16007118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite instability, Epstein-Barr virus, mutation of type II transforming growth factor beta receptor and BAX in gastric carcinomas in Hong Kong Chinese.
    Leung SY; Yuen ST; Chung LP; Chu KM; Wong MP; Branicki FJ; Ho JC
    Br J Cancer; 1999 Feb; 79(3-4):582-8. PubMed ID: 10027334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells.
    Biswas S; Trobridge P; Romero-Gallo J; Billheimer D; Myeroff LL; Willson JK; Markowitz SD; Grady WM
    Genes Chromosomes Cancer; 2008 Feb; 47(2):95-106. PubMed ID: 17985359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer.
    Kang SH; Bang YJ; Im YH; Yang HK; Lee DA; Lee HY; Lee HS; Kim NK; Kim SJ
    Oncogene; 1999 Dec; 18(51):7280-6. PubMed ID: 10602482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.
    Grady WM; Myeroff LL; Swinler SE; Rajput A; Thiagalingam S; Lutterbaugh JD; Neumann A; Brattain MG; Chang J; Kim SJ; Kinzler KW; Vogelstein B; Willson JK; Markowitz S
    Cancer Res; 1999 Jan; 59(2):320-4. PubMed ID: 9927040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta type II receptor expression in gastric cancer: evidence for two independent subgroups.
    Takeno S; Wirtz HC; Lickvers K; Noguchi T; Scheven M; Willers R; Gabbert HE; Mueller W
    Anticancer Res; 2002; 22(4):2247-52. PubMed ID: 12174910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.